Related Experiment Videos
Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic
Abstract:
Primates and rodents show marked differences in sensitivity to the neurotoxic effects of MPTP. We and others have previously shown that the toxic effects of MPTP on nigrostriatal cells are dependent on the oxidative metabolism of MPTP to the quaternary species MPP+. We have therefore compared the distribution and metabolism of MPTP in the monkey and several rodent species. Three major differences have been identified: 1) the primate, but not the rodents, showed a persistently high concentration of MPTP metabolites in the caudate nucleus compared to other brain regions; 2) the rodent brains cleared MPTP and its metabolites much more rapidly than did the monkey, and; 3) the predominant metabolite retained by the monkey brain was MPP+, while MPP+ cannot be detected in rodent brains for more than a few hours after injection. The persistence of MPP+ in the primate brain may explain the heightened toxicity of MPTP in this species.
Insights
Primates are more sensitive to MPTP neurotoxicity than rodents because their brains retain MPP+ longer. This difference in MPTP metabolite distribution explains the heightened toxicity observed in primates.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) causes neurotoxicity, particularly affecting nigrostriatal cells.
- The toxic effects of MPTP are linked to its oxidative metabolism into the MPP+ (1-methyl-4-phenylpyridinium) species.
- Species-specific differences in MPTP sensitivity exist between primates and rodents.
Purpose of the Study:
- To compare the distribution and metabolism of MPTP in primate (monkey) and rodent brains.
- To elucidate the reasons behind the differential sensitivity to MPTP neurotoxicity between these species.
Main Methods:
- Administration of MPTP to monkeys and several rodent species.
- Analysis of MPTP and its metabolite MPP+ distribution and concentration in different brain regions over time.
- Comparative pharmacokinetic analysis between species.
Main Results:
- Primates exhibited persistently high concentrations of MPTP metabolites, specifically MPP+, in the caudate nucleus compared to other brain regions.
- Rodent brains cleared MPTP and its metabolites significantly faster than primate brains.
- MPP+ was the predominant retained metabolite in primate brains, whereas it was not detectable in rodent brains after a few hours.
Conclusions:
- The prolonged retention of MPP+ in the primate brain, particularly in the caudate nucleus, is a key factor contributing to the heightened neurotoxicity of MPTP in this species.
- Rapid clearance of MPTP and its metabolites in rodents likely contributes to their lower sensitivity to MPTP's toxic effects.